Intellectual Property Right (IPR) protection is biggest challenge for foreign company operating in China, the intellectual property leakage becomes a new barrier to multinational company. IP leakage often occurs through staff transfers or shared practices to local partner when entering into Chinese market. The medical device company should develop IPR protection measures to reduce the loss of IP and remove the barrier of IP leakage in China.
CIRS RA team specialized in developing solutions of IPR protection for you that enable you to shift some innovation capabilities to China safely and without losing critical know-how.
Please join in our “China Medical Device Regulatory Assistant Program” for free proposal. For complex and urgent projects, we will assign a dedicated project manager to customize a program specific to your requirements. We are ready to be of service at any time.
Contact Us
Mr. Edwin Wen China office
Tel: +86 571 8720 6541 | Fax: +86 571 8720 6533
Email: Edwin.wen@cirs-group.com
Mr. Michael Petersen China office
Tel: +86-571 8720 6559 | Fax: +86-571 8720 6533
Email: Elaine@cirs-group.com
